Laughing gas may not mess with Kids' lung germs
NCT ID NCT07118644
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looked at whether using a gas called MEOPA (laughing gas) to calm children during a lung sample procedure changes the types of bacteria found in their airways. 23 children aged 3 months to 8 years old took part. The goal was to see if the gas affects the accuracy of the bacteria test results.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- MEOPA (a gas with pain-relieving and anxiety-reducing properties, also known as laughing gas)
- What this could lead to
- If it works, this could show that using MEOPA does not interfere with lung bacteria samples, making the procedure more comfortable for children without affecting test results.
- What could go wrong
- This is a very small study (23 children) looking only at short-term changes in bacteria, not at health outcomes. The results may not apply to all children or settings.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 3
Large-scale testing in a bigger group. Usually the last step before a treatment can be approved.
- Participants
-
23 people
The number who actually took part.
- Started
-
Sep 2025
- Finished
-
Mar 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
3 months to 8 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Children aged from 3 months to 8 years old * Patients requiring ECBC in routine practice: acute respiratory distress with suspected bacterial respiratory infection (superinfected bronchiolitis or asthma attack, suspected pneumonia) and severe asthma assessment * Child unable to expectorate effectively * Free, informed and written consent of the minor patient's legal guardians; * Enrolled in the social security system. Exclusion Criteria: 1. Contraindication of MEOPA : * Patients requiring 100% oxygen ventilation * Intracranial hypertension * Altered state of consciousness preventing cooperation * Any condition where air is trapped inside the body and expansion could be dangerous (cranial and/or maxillofacial trauma, pneumothorax, emphysema, gas embolism, following recent scuba diving, decompression sickness following gas encephalography, during middle ear/internal ear or sinus surgery, abdominal gas distension, when air is injected into the epidural space during epidural anesthesia, if the patient has received ophthalmic gas (SF6, C3F8, C2F6) used in eye surgery for as long as the gas bubble persists and up to 3 months afterwards) * Known, unsubstituted vitamin B12 or folic acid deficiency * Recent, unexplained neurological abnormalities 2. Contraindications to induced expectoration : * Clinical instability not conducive to induced expectoration (at practitioner's discretion) * Severe respiratory insufficiency, * Severe spasticity. * Hemoptysis * Decompensated heart failure * Contraindication of hypertonic saline : * Hypersensitivity of the bronchial system to hypertonic sodium chloride solutions. * Hemoptysis * Contraindication to the use of Salbutamol : * Hypersensitivity to any of the constituents of salbutamol-based pressurized or inhaled products. * Intolerance to salbutamol-based pressurized or inhaled products (coughing or bronchospasm occurring immediately after inhalation of the product). * Contraindication of the maneuver performed by the physiotherapist: bullous emphysema, confirmed hiatal or diaphragmatic hernia and rib fragility. 3. Patient with minor parent(s) 4. Uncooperative child 5. Antibiotic therapy administered within the previous 24 hours.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Children are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Brest, University Hospital
Brest, 29609, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a local anesthetic injection curb Kids' pain after tonsil removal?
- Two ways to rebuild a Child's bone: which holds up?
- A simple diary might ease the trauma of a Child's ICU stay
- Could toothbrushing drills in schools cut childhood cavities?
- Paper craft may calm children before heart procedures
- Could ten classroom sessions build stronger, happier kids?